drug

tacabrutideg

1 story · latest Aug 26, 2026

Status: Investigational
Code: BGB-16673
Trials: 2 registered trials in coverage

Relationships

Developed by BeiGene

Timeline

BeOne Medicines files STAR Market interim report, discloses R&D spend by product under US GAAP

Aug 26Quarterly updateBeiGene

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.